Search company, investor...
SONIC innovations company logo

SONIC innovations

sonici.com

Founded Year

1997

Stage

Unattributed VC - VI | Alive

Total Raised

$35.13M

Last Raised

$12M | 16 yrs ago

About SONIC innovations

SONIC Innovations offers digital hearing aids

Headquarters Location

2795 East Cottonwood Parkway Suite 660

Salt Lake City, Utah, 84121,

United States

801-365-2800

Missing: SONIC innovations's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: SONIC innovations's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

SONIC innovations Patents

SONIC innovations has filed 12 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/14/2014

4/4/2017

Fluid dynamics, Fluid mechanics, Flow meters, Sensors, Aerodynamics

Grant

Application Date

4/14/2014

Grant Date

4/4/2017

Title

Related Topics

Fluid dynamics, Fluid mechanics, Flow meters, Sensors, Aerodynamics

Status

Grant

Latest SONIC innovations News

Ear Nose Throat (ENT) Treatment Market Size to Hit US$ 27.95 Bn by 2030

Feb 15, 2022

Companies Covered Novartis AG, GlaxoSmithKline Pharmaceuticals, Pfizer Inc., Teva Pharmaceuticals Industries Ltd., Sonova Holding AG, Sonic Innovations Inc., Starkey Laboratories Inc., Siemens Healthcare, American Hearing Systems Inc., Dr. Reddy’s Laboratories Ltd. Report Highlights: Based on the devices, the hearing aid devicessegment dominated the global ear nose throat (ENT) treatment market in 2020 with highest market share. Increased demand for hearing aids is responsible for the substantial proportion of the ear nose throat (ENT) treatment market. Hearing loss can result from changes in the neural connections from the ear to the brain as people age. North America is the largest segment for ear nose throat (ENT) treatment market in terms of region. This is due to growing advantageous reimbursement scenario for ear nose throat (ENT) treatments as well as strong presence of significant participants in this region. Furthermore, the ear nose throat (ENT) treatment market in the region is driven by rising awareness leading to recognition of ear nose throat (ENT) devices. Asia-Pacific region is the fastest growing region in the ear nose throat (ENT) treatment market. This is attributed to the increased knowledge of ear nose throat (ENT) devices, rising number of patients suffering from sinusitis, and an increase in the older population. Ask here for more customization study@ https://www.precedenceresearch.com/customization/1534 Future of Ear Nose Throat (ENT) Treatment Market Despite the fact that many medical insurance companies do not fund cosmetic ear nose throat (ENT) operations, such as cosmetic rhinoplasty and otoplasty, there is a growing demand for these procedures. Some of the major factors encouraging people to spend for cosmetic ear nose throat (ENT) procedures to improve their appearance include technological advancements, less invasive procedures, higher popularity, safety, and accessibility of most cosmetic procedures, a rebounding economy, and rising disposable incomes in emerging economies. As a result, the rising demand for aesthetic ear nose throat (ENT) operations opens up a plethora of potential for the ear nose throat (ENT) devices market to expand in the upcoming years. COVID-19 Impact Analysis: The COVID-19 pandemic had a substantial impact on hospital resources around the world. This has largely been accomplished by drastically lowering inpatient and outpatient services for various diseases as well as adopting infection prevention and control methods. The number of ear nose throat (ENT) diseases screening and diagnostic procedures dropped dramatically, with the pandemic affecting nations all over the globe. Key Developments in the Marketplace: By building World of Hearing, a new hearing solution store in the Netherlands, Sonova Holding AG wants to expand its ENT product development and commercial manufacture in 2020. Hearing aid fittings can now be conducted remotely, thanks to new technology developed by Sonova Holding AG. In December 2015, Otonomy Inc. received FDA permission for the marketing of their new antibiotic OTIPRIO, which is used to treat young patients with bilateral otitis media. In September 2019, Cochlear Limited and GN Hearing teamed up with Google to introduce support for direct Bluetooth Low Energy streaming from Android devices to hearing aids. In March 2020, WS Audiology introduced WIDEX MOMENT, the first generation of natural-sounding hearing aids. This is achievable because to Widex'sZeroDelay Technology. Related Reports Buy this Premium Research Report@  https://www.precedenceresearch.com/checkout/1534 You can place an order or ask any questions, please feel free to contact at  sales@precedenceresearch.com  | +1 9197 992 333 About Us Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally. For Latest Update Follow Us:

SONIC innovations Frequently Asked Questions (FAQ)

  • When was SONIC innovations founded?

    SONIC innovations was founded in 1997.

  • Where is SONIC innovations's headquarters?

    SONIC innovations's headquarters is located at 2795 East Cottonwood Parkway, Salt Lake City.

  • What is SONIC innovations's latest funding round?

    SONIC innovations's latest funding round is Unattributed VC - VI.

  • How much did SONIC innovations raise?

    SONIC innovations raised a total of $35.13M.

  • Who are the investors of SONIC innovations?

    Investors of SONIC innovations include RG Capital, Enable Capital Management, AWM Investment Company, UBS, Blueline Partners and 11 more.

  • Who are SONIC innovations's competitors?

    Competitors of SONIC innovations include Lucina Health, TrueVision Systems, Corpora Systems, FluimediX, Insound Medical and 12 more.

Compare SONIC innovations to Competitors

V
Vast Audio

VAST Audio leverages its acoustics platform technology to develop DSP technologies involving the application of advanced sensory processing techniques to 3D hearing devices. The Company is developing a spatial hearing aid to effectively support listening in both noisy and quiet environments. The hearing aid is based on the company's Completely-in-Canal (CIC) earphone and aims to provide the perceptual basis for segregating talkers in noisy environments and will lead to vast improvement in speech segregation and intelligibility.

B
BioMimetic Systems

BioMimetic Systems (BMS) is developing biologically inspired technologies for advanced sensors and medical devices. BMS has its roots in the Boston University Hearing Research Center and VLSI laboratories with more than 30 years of experience researching the physiology and biophysics of hearing as well as specialized custom electronics. The focus of BMS is the application of biologically inspired algorithms to technically challenging problems that traditional approaches have failed to address. Applications include sensor design for high noise environments as well as medical devices for the hearing impaired.

Moximed Logo
Moximed

Moximed is a developer of unicompartmental load absorber implants for active patients with painful knee osteoarthritis (OA). The Moximed implants do not require bone cutting or bone removal, and, importantly, they absorb excess joint load rather than shift load to other areas of the joint. The company is based in Fremont, California.

A
Ark Sciences

Ark Sciences LLC develops pharmaceutical products for animals and their pharmaceutical products are specifically engineered to provide the least invasive, non-surgical sterilization processes possible. Rather than castrating dogs, which can be painful and lead to possibly harmful side-effects, with Ark Sciences' patent protected products, veterinarians and animal welfare specialists have a safe, reliable and cost-effective sterilization treatment.

Neuros Medical Logo
Neuros Medical

Neuros Medical focuses on the development of proprietary therapies for the unmet needs of patients worldwide. The company's Altius system treats chronic post-amputation pain (Phantom Limb Pain and Residual Limb Pain). Altius incorporates the Company’s patented platform technology, On-Demand Bioelectric Nerve Block. Patients initiate a 30-minute Altius treatment session as needed for targeted pain relief. Neuros Medical was founded in 2008 and is based in Willoughby, Ohio.

F
FluimediX

FluimediX is in the process of developing the NanoCycler device. The NanoCycler is a tabletop device designed to accept a disposable polymer cartridge, in which a number of biochemical reactions are performed on a human saliva sample. The NanoCycler will deliver an identification of the presence of - respectively lack of - a number of genetic mutations; the so-called SNPs - Single Nucleotide Polymorphisms.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.